| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 929.48 | 95 |
| GSM780708 | Untreated after 4 days (C2_1) | 931.77 | 95 |
| GSM780709 | Untreated after 4 days (C3_1) | 1060.97 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 864.102 | 95 |
| GSM780720 | Untreated after 4 days (C2_2) | 1006.86 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1020.47 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 905.728 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 864.102 | 95 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 923.774 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1020.47 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 947.628 | 95 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 942.607 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 893.422 | 95 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 902.931 | 95 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 800.767 | 94 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 919.055 | 95 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 854.728 | 95 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 802.999 | 94 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 871.887 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 939.533 | 95 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 937.806 | 95 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 967.756 | 95 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 969.961 | 95 |